Criteria for the pathogenicity of anticentromere (anti-CENP-B) autoantibodies in systemic sclerosis: comment on the article by van Leeuwen et al

Arthritis Rheumatol. 2022 Sep;74(9):1606-1607. doi: 10.1002/art.42159. Epub 2022 Aug 9.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Autoantibodies*
  • Autoantigens
  • Centromere Protein B
  • Humans
  • Scleroderma, Systemic*
  • Virulence

Substances

  • Autoantibodies
  • Autoantigens
  • Centromere Protein B

Grants and funding